Last reviewed · How we verify

Lactic acid (Dermacyd Femina)

Sanofi · Phase 3 active Small molecule

Lactic acid (Dermacyd Femina) is a Vaginal acidifying agent Small molecule drug developed by Sanofi. It is currently in Phase 3 development for Vaginal hygiene and prevention of vaginal infections, Treatment of vulvovaginal candidiasis, Maintenance of normal vaginal microflora.

Lactic acid maintains vaginal pH and creates an acidic environment that inhibits the growth of pathogenic bacteria and fungi.

Lactic acid maintains vaginal pH and creates an acidic environment that inhibits the growth of pathogenic bacteria and fungi. Used for Vaginal hygiene and prevention of vaginal infections, Treatment of vulvovaginal candidiasis, Maintenance of normal vaginal microflora.

At a glance

Generic nameLactic acid (Dermacyd Femina)
SponsorSanofi
Drug classVaginal acidifying agent
ModalitySmall molecule
Therapeutic areaGynecology / Women's Health
PhasePhase 3

Mechanism of action

Lactic acid is a naturally occurring organic acid that restores and maintains the acidic pH of the vaginal microenvironment (pH 3.8–4.5). By lowering pH, it suppresses the growth of opportunistic pathogens such as Candida species and gram-negative bacteria while promoting the growth of beneficial lactobacilli. This mechanism helps prevent and treat vaginal infections and maintain normal vaginal flora.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lactic acid (Dermacyd Femina)

What is Lactic acid (Dermacyd Femina)?

Lactic acid (Dermacyd Femina) is a Vaginal acidifying agent drug developed by Sanofi, indicated for Vaginal hygiene and prevention of vaginal infections, Treatment of vulvovaginal candidiasis, Maintenance of normal vaginal microflora.

How does Lactic acid (Dermacyd Femina) work?

Lactic acid maintains vaginal pH and creates an acidic environment that inhibits the growth of pathogenic bacteria and fungi.

What is Lactic acid (Dermacyd Femina) used for?

Lactic acid (Dermacyd Femina) is indicated for Vaginal hygiene and prevention of vaginal infections, Treatment of vulvovaginal candidiasis, Maintenance of normal vaginal microflora.

Who makes Lactic acid (Dermacyd Femina)?

Lactic acid (Dermacyd Femina) is developed by Sanofi (see full Sanofi pipeline at /company/sanofi).

What drug class is Lactic acid (Dermacyd Femina) in?

Lactic acid (Dermacyd Femina) belongs to the Vaginal acidifying agent class. See all Vaginal acidifying agent drugs at /class/vaginal-acidifying-agent.

What development phase is Lactic acid (Dermacyd Femina) in?

Lactic acid (Dermacyd Femina) is in Phase 3.

What are the side effects of Lactic acid (Dermacyd Femina)?

Common side effects of Lactic acid (Dermacyd Femina) include Local irritation or burning, Mild discomfort.

Related